Considering rationales for use in defining subgroups for the treatment of stimulant use disorder
Olivia Brooks(University of British Columbia), Kanna Hayashi(Simon Fraser University), Paxton Bach(University of British Columbia)
Cited by 3
Related Papers
Characterization of Environmental Sources of the Human and Animal Pathogen <i>Cryptococcus gattii</i> in British Columbia, Canada, and the Pacific Northwest of the United States
|Applied and Environmental Microbiology|2006|238
Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction
|Journal of General Internal Medicine|2019|150
Expansion of Antigen-Specific Regulatory T Cells with the Topical Vitamin D Analog Calcipotriol
|The Journal of Immunology|2009|148
<i>Cryptococcus gattii</i>Dispersal Mechanisms, British Columbia, Canada
|Emerging infectious diseases|2007|146
Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study
|Drug and Alcohol Dependence|2020|119